Navigation Links
Royal DSM and JLL create leading pharma services company in USD 2.6 bn transaction
Date:11/18/2013

related to future general economic and market conditions; and other matters. Patheon's and Newco's beliefs and assumptions are inherently subject to significant business, economic, competitive and other uncertainties and contingencies regarding future events and as such, are subject to change. Patheon's beliefs and assumptions may prove to be inaccurate and consequently Patheon's actual results could differ materially from the expectations set out herein.

While such forward-looking statements are expressed by Patheon, as stated in this release, in good faith and believed by Patheon to have a reasonable basis, they are subject to important risks and uncertainties including, without limitation, the possibility that certain assumptions with respect to the proposed transaction could prove to be inaccurate, risks and uncertainties relating to the transaction and financing thereof, Newco's significant levels of indebtedness as a result of the proposed transaction, Newco's inability to complete the anticipated financing as contemplated by applicable commitment letters prior to the contractually required time for closing of the proposed transaction or otherwise secure favourable terms for such financing, approval of applicable governmental authorities, required Patheon shareholder approval and necessary court approvals, the satisfaction or waiver of certain other conditions contemplated by the Arrangement Agreement, disruptions resulting from the proposed transaction making it more difficult to maintain business relationships, and changes in applicable laws or regulations, which could cause actual results to differ materially from future results expressed, projected or implied by the forward-looking statements. As a result of these risks and uncertainties, the proposed transaction could be modified, restructured or may not be completed, and the results or events predicted in these forward-looking statements may differ materially from actual results or events. These
'/>"/>

SOURCE Royal DSM
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related medicine technology :

1. AcelRx Pharmaceuticals Hires Mike A. Royal, M.D. as Chief, Clinical Affairs
2. Royalty Rates Take Center Stage in Biopharma Dealmaking
3. Home Affairs Committees Drugs Report: Angelus Foundation Says the Prime Minister Should Not Have Rejected a Royal Commission
4. NeuroSigma Invited to Present an Overview of eTNS for the Treatment of Epilepsy and Depression at The Royal Society of Medicine in London
5. Royalty Pharma Announces Proposal To Acquire Elan
6. PDL BioPharma Provides First Quarter 2013 Royalty Revenue Guidance of $92 Million
7. Royalty Rates for Pharmaceuticals & Biotechnology: Real-Deal Information for Hundreds of Transactions
8. PDL BioPharma Completes Structured Financing and Royalty Transaction with Avinger
9. Selexis SA Sells Rights to Royalty Payments for More Than 15 Biologic Development Programs to Ligand Pharmaceuticals
10. Royalty Pharma Increases Offer for Elan to $12.50 Per Share in All Cash
11. Royalty Pharma Reduces Acceptance Condition to 50% Plus One Share
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/30/2014)... ALBANY, New York , September 30, 2014 /PRNewswire/ ... Market - Global Industry Analysis, Market Size, Share, Growth ... Research is expected to be worth USD 20.8 billion ... 29.5 billion in 2017, growing at a CAGR of ... are fundamental elements needed for various health purposes, especially ...
(Date:9/30/2014)...   Decision Resources Group finds that through ... kidney disease non-dialysis (CKD-ND) patients are not highly ... addition, one-year persistency is similar between Amgen,s Aranesp ... findings from the report entitled Treatment ... Agents in Late Stage Chronic Kidney Disease and ...
(Date:9/30/2014)... SAN DIEGO , 30. September ... Logo - http://photos.prnewswire.com/prnh/20130430/LA01948LOGO ... ein Medizintechnikunternehmen, das ein minimal-invasives 3D-Herzkammer-Bildgebungs- ... der Ursachen entwickelt, die zu komplexen ... aufrechterhalten, hat den Abschluss einer zusätzlichen ...
Breaking Medicine Technology:Nutraceutical Ingredient Market Will Reach USD 33.6 Billion Globally in 2018: Transparency Market Research 2Nutraceutical Ingredient Market Will Reach USD 33.6 Billion Globally in 2018: Transparency Market Research 3Nutraceutical Ingredient Market Will Reach USD 33.6 Billion Globally in 2018: Transparency Market Research 4Persistency is Low for Late-Stage Anemic CKD Non-Dialysis Patients Treated with Erythropoiesis-Stimulating Agents 2Persistency is Low for Late-Stage Anemic CKD Non-Dialysis Patients Treated with Erythropoiesis-Stimulating Agents 3Acutus Medical, Inc. schließt zusätzliche Finanzierungsrunde Serie B über 26,2 Mio. USD ab, um Portfolio-Erweiterung zu finanzieren 2Acutus Medical, Inc. schließt zusätzliche Finanzierungsrunde Serie B über 26,2 Mio. USD ab, um Portfolio-Erweiterung zu finanzieren 3
... InteKrin Therapeutics, Inc., a clinical stage biopharmaceutical company ... has completed enrollment of a 360 patient Phase 2b ... PPAR gamma (SPPARM) for the treatment of Type 2 ... dose active comparator (45mg Actos(R)) and placebo controlled study ...
... the nation,s economic slowdown, America,s pharmaceutical research and ... year in the research and development of new ... roughly $2 billion from 2007, according to analyses ... (PhRMA) and Burrill & Company. PhRMA-member companies ...
Cached Medicine Technology:InteKrin Therapeutics Announces Enrollment Completion of 360 Patient, 24 week Phase 2b Study 2R&D Spending by U.S. Biopharmaceutical Companies Reaches Record Levels in 2008 Despite Economic Challenges 2R&D Spending by U.S. Biopharmaceutical Companies Reaches Record Levels in 2008 Despite Economic Challenges 3R&D Spending by U.S. Biopharmaceutical Companies Reaches Record Levels in 2008 Despite Economic Challenges 4
(Date:9/30/2014)... HealthDay Reporter TUESDAY, Sept. 30, ... to put the brakes on motherhood. And for many young ... choice, new research suggests. Women in their early 20s ... during tough economic times. But, according to the new study, ... their 40s and beyond. The findings suggest that higher ...
(Date:9/30/2014)... the leading cause of cancer death in women, according ... medical professionals encourage women to get mammograms, even though ... of suspicious mammograms actually leads to a cancer diagnosis. ... women and their familiesnot to mention the time, discomfort ... , Recently, a different type of test, ultrasound ...
(Date:9/30/2014)... Dynamic health trends, changing consumer ... the Bread Production industry over the past five ... their consumption of a variety of industry goods ... the market for white loaf bread and other ... introducing more nutritious products to attract health-conscious consumers, ...
(Date:9/30/2014)... of Maryland-led research team has been awarded a ... of Health (NIH) to develop new imaging technologies ... understanding of how large networks of neurons in ... knowledge will help researchers identify the precise interactions ... like decision-making and speaking, and alterations in these ...
(Date:9/30/2014)... September 30, 2014 The American ... to help diabetics curb their sweet tooth, but the ... this September, suggests that zero-calorie sweeteners may actually ... diabetes. , The Weizmann Institute of Science in ... artificial sweeteners to mice, the mice developed glucose intolerance. ...
Breaking Medicine News(10 mins):Health News:Recessions May Thwart a Woman's Motherhood Plans Forever: Study 2Health News:Recessions May Thwart a Woman's Motherhood Plans Forever: Study 3Health News:'Virtual breast' could improve cancer detection 2Health News:Bread Production in the US Industry Market Research Report from IBISWorld Has Been Updated 2Health News:Bread Production in the US Industry Market Research Report from IBISWorld Has Been Updated 3Health News:UMD receives inaugural BRAIN Initiative Award 2Health News:Artificial Sweeteners May be Linked to Greater Diabetes Risk 2
... Though nursing is thought to reduce risk, more advanced tumors ... Women who breast-feed for six months or more face a ... cancer, but it,s not clear whether there,s a cause-and-effect relationship, ... these women are more likely to die of cancer than ...
... ... Experience in Style , ... March 26, 2010 -- Last week EarPeace provided hearing protection to thousands of music ... bands over the course of four days. The average decibel level at a concert is ...
... ... local and national organizations to help individuals in need. , ... Munster, IN (PRWEB) March 26, 2010 -- ... its efforts in giving back to the community and helping individuals in need of ...
... alcohol use tied to better lifestyle habits, study finds ... take worse care of themselves than other people, but ... who don,t imbibe, researchers have found. , "The main ... other behaviors -- such as relieving stress with alcohol ...
... beta-blockers can help reduce the spread of cancer in ... seventh European Breast Cancer Conference (EBCC7) in Barcelona today ... senior healthcare research scientist at Queen,s Medical Centre, Nottingham ... found that the group of patients treated with beta-blockers ...
... Spain: Two studies to be presented at the seventh ... and tomorrow (Saturday), shed light on the treatment options ... which predispose them to breast cancer. In the first, ... of Medical Oncology, Erasmus Medical Centre, Rotterdam, The Netherlands, ...
Cached Medicine News:Health News:Long-Term Breast-Feeding Tied to More Aggressive Cancers 2Health News:EarPeace Protects Hearing for Thousands at South by Southwest 2Health News:Stirling Dental Laboratory, Experts in Emergency Denture Repair Service, Gives Back to Community 2Health News:Stirling Dental Laboratory, Experts in Emergency Denture Repair Service, Gives Back to Community 3Health News:Heavy Daily Drinking Linked to Worse Health 2Health News:Beta-blockers help reduce metastasis and improve survival in breast cancer patients 2Health News:New studies on surgical options in inherited breast cancer show drastic treatment is not always best 2Health News:New studies on surgical options in inherited breast cancer show drastic treatment is not always best 3Health News:New studies on surgical options in inherited breast cancer show drastic treatment is not always best 4
Solid State Manometry Catheter Accessory., ,Manometric calibrators are required for calibration of solid state catheters., ,Each type of catheter requires a unique calibrator....
Sphincter of Oddi Solid State Catheter Adapter Cable for Polygraf ID...
... The ITREL 3 is a battery powered ... the U.S., ,Enterra™ Therapy is indicated ... vomiting associated with gastroparesis when conventional drug ... symptons for diabetic or idiopathic patients., ...
... rapid qualitative test for detection of cardiac ... samples. It can be used as an ... and can be useful to assess if ... angina (e.g. gastric pain, strained chest muscles, ...
Medicine Products: